Equifax (NYSE:EFX) Updates FY 2024 Earnings Guidance

Equifax (NYSE:EFX) issued an update on its FY 2024 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 7.250-7.350 for the period, compared to the consensus earnings per share estimate of 7.360. The company issued revenue guidance of $5.7 billion-$5.7 billion, compared to the consensus revenue estimate of $5.7 billion. Equifax also updated its FY24 guidance to $7.25-7.35 EPS.

Wall Street Analyst Weigh In

EFX has been the subject of a number of research reports. Needham & Company LLC boosted their target price on shares of Equifax from $305.00 to $320.00 and gave the stock a “buy” rating in a research note on Friday, July 19th. Bank of America increased their target price on Equifax from $255.00 to $286.00 and gave the company a “buy” rating in a report on Thursday, July 18th. Citigroup raised their price objective on Equifax from $263.00 to $304.00 and gave the company a “buy” rating in a report on Wednesday, July 24th. Morgan Stanley upped their target price on shares of Equifax from $250.00 to $271.00 and gave the stock an “equal weight” rating in a report on Thursday, September 12th. Finally, Oppenheimer raised their price target on shares of Equifax from $300.00 to $315.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 8th. Four equities research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $307.74.

Equifax Stock Down 0.1 %

Equifax stock opened at $289.95 on Thursday. The company has a market capitalization of $35.84 billion, a PE ratio of 64.58, a price-to-earnings-growth ratio of 2.00 and a beta of 1.58. The company has a debt-to-equity ratio of 1.01, a quick ratio of 0.79 and a current ratio of 0.79. Equifax has a fifty-two week low of $159.95 and a fifty-two week high of $309.63. The firm has a 50 day moving average price of $294.89 and a 200 day moving average price of $262.68.

Equifax (NYSE:EFX) last posted its quarterly earnings data on Wednesday, October 16th. The credit services provider reported $1.85 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.84 by $0.01. The firm had revenue of $1.44 billion for the quarter, compared to the consensus estimate of $1.44 billion. Equifax had a return on equity of 18.88% and a net margin of 10.67%. The company’s quarterly revenue was up 9.3% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.76 EPS. Research analysts expect that Equifax will post 7.36 earnings per share for the current year.

Equifax Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, September 13th. Stockholders of record on Tuesday, September 3rd were given a dividend of $0.39 per share. This represents a $1.56 dividend on an annualized basis and a dividend yield of 0.54%. The ex-dividend date was Tuesday, September 3rd. Equifax’s dividend payout ratio is currently 34.74%.

Insider Activity

In other Equifax news, EVP Carla Chaney sold 3,000 shares of the company’s stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $281.85, for a total transaction of $845,550.00. Following the sale, the executive vice president now owns 10,875 shares in the company, valued at $3,065,118.75. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 1.57% of the company’s stock.

Equifax Company Profile

Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.